Skip to content

Neuronetics, Inc.

STIM· NasdaqCore metricsCIK 1227636
Last sale
Nov 6, 2026 · -12.09%
Market cap
$166.73M
77.73M shares
Filings
727
$41.96M
Q3 2026+99.2% FY25 yoy
-$1.69M
Q3 2026N/M FY25 yoy
$541.00K
Q3 2026N/M FY25 yoy
-$10.28M
Q3 2026derivedN/M FY25 yoy
-$0.02
Q3 2026N/M FY25 yoy
$22.11M
Q3 2026+52.4% FY25 yoy
$166.73M
—
1.0×
8.9×
-5.76%
—

Twelve months to Sep 30, 2026 · derived

Financials

Revenue

$149.16MFY 2025
$149.16M0FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$149,157,000reported
FY 20242024-12-31$74,890,000reported
FY 20232023-12-31$71,348,000reported
FY 20222022-12-31$65,206,000reported
FY 20212021-12-31$55,312,000reported
FY 20202020-12-31$49,244,000reported
FY 20192019-12-31$62,656,000reported
FY 20182018-12-31$52,776,000reported
FY 20172017-12-31$40,433,000reported
FY 20162016-12-31$34,228,000reported

Segments

Revenue by Segments, FY2022 to FY2025FY2022Medical Device Segment · FY2022 · $65.21MFY2023Medical Device Segment · FY2023 · $71.35MFY2024Clinical Services Segment · FY2024 · $4.45MMedical Device Segment · FY2024 · $70.45MFY2025Clinical Services Segment · FY2025 · $86.98MMedical Device Segment · FY2025 · $62.18M
LineFY2025ShareChange
Clinical Services Segment$86.98M58%+1,856.7%
Medical Device Segment$62.18M42%−11.7%
Total$149.16M

From the 10-K filed Mar 17, 2026STIM

Neuronetics, Inc. · CIK 1227636 · Engraved from SEC EDGAR